Skip to main content

Table 1 Abnormal and subclinical conditions associated with risk of venous thromboembolism and cardiovascular disease in polycystic ovary syndrome

From: Risks, benefits size and clinical implications of combined oral contraceptive use in women with polycystic ovary syndrome

Central obesity

Systemic arterial hypertension

Hyperandrogenemia

Impaired glucose tolerance

Insulin resistance

Type II diabetes mellitus

Metabolic syndrome

Dyslipidemia

Nonalcoholic fatty liver disorder

Low-grade chronic inflammatory disease

Obstructive sleep apnea

Subclinical vascular disease

Back to article page

Reproductive Biology and Endocrinology

ISSN: 1477-7827

Contact us